HUTCHMED (China) (HMDCF) Treasury Shares (2016 - 2025)
HUTCHMED (China)'s (HMDCF) quarterly Treasury Shares came in at $15.4 million in Q4 2025, down 63.34% year-over-year from $42.1 million in Q4 2024, and down 63.34% quarter-over-quarter from $42.1 million in Q4 2024.
Analysis
HUTCHMED (China) (HMDCF) Treasury Shares (2016 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Treasury Shares for 10 consecutive years, with $15.4 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Treasury Shares fell 63.34% year-over-year to $15.4 million in Q4 2025; TTM through Dec 2025 was $15.4 million, a 63.34% decrease from a year earlier, with the FY2025 full-year figure at $15.4 million, down 63.34% from the prior year.
- Treasury Shares was $15.4 million for Q4 2025 at HUTCHMED (China), down from $42.1 million in the prior quarter.
- Over five years, Treasury Shares peaked at $42.1 million in Q4 2024 and troughed at $1.4 million in Q4 2021.
- A 5-year average of $17.8 million and a median of $15.4 million in 2025 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares sank 69.97% in 2021 and soared 729.93% in 2022, its largest moves.
- Over 5 years, Treasury Shares stood at $1.4 million in 2021, then soared by 729.93% to $12.0 million in 2022, then surged by 50.81% to $18.1 million in 2023, then surged by 132.13% to $42.1 million in 2024, then tumbled by 63.34% to $15.4 million in 2025.
- The last three Treasury Shares figures came in at $15.4 million (Q4 2025), $42.1 million (Q4 2024), and $18.1 million (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | 36.40 Mn |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | -23.80 Mn |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | - |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15.44 Mn |
| Dec 31, 2025 | 15.44 Mn |
| Dec 31, 2024 | 42.13 Mn |
| Dec 31, 2024 | 42.13 Mn |
| Dec 31, 2023 | 18.15 Mn |
| Dec 31, 2023 | 18.15 Mn |
| Dec 31, 2022 | 12.03 Mn |
| Dec 31, 2022 | 12.03 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Dec 31, 2020 | 4.83 Mn |
| Dec 31, 2020 | 4.83 Mn |
| Dec 31, 2019 | 944,000.00 |
| Dec 31, 2019 | 944,000.00 |
| Dec 31, 2018 | 731,000.00 |
| Dec 31, 2018 | 731,000.00 |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2017 | 1.80 Mn |
| Dec 31, 2016 | 62,921.00 |
| Dec 31, 2016 | 62,921.00 |